Mosenzon O, Raz I, Wiviott SD, Schechter M, et al. Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes-Post Hoc Analyses From the DECLARE-TIMI 58 Trial. Diabetes Care 2022 Aug 23. pii: 147474. doi: 10.2337/dc22-0382.
PMID: 35997319